Smart Pills Market Size, Share, By Target Area (Small Intestine, Large intestine, Stomach, and Esophagus), By Application (Drug Delivery, Capsule Endoscopy and Others), By End-Users (Hospitals, Diagnostic Centers, Specialty Clinics and Research Institutes) and By Region - Trends, Analysis and Forecast till 2032

Smart Pills Market accounted for USD 497.2 Million in 2022 and is estimated to be USD 2068.48 Million by 2032 and is anticipated to register a CAGR of 15.4%.

Jerome Schentag has invented Smart pills which is the capsule that helps in controlling rate and amount of medicine received by patient after swallowed. Smart pills are ingestible sensors which are swallowed and can able to record different physiological measures. Smart pills are also used for confirmation that patient has taken his or her prescribed medication and also helps in measuring effects of medication.This smart pill technology is also used in delivering drugs to certain areas of the body and carry tiny cameras for providing images of colon. Smart pills includes amphetamine and methylphenidate used in treating attention deficit hyperactivity disorder or ADHD. Smart pills are also used in diagnosis and treatment of gastrointestinal disease.

Smart pills has revolutionized diagnosis of gastrointestinal disorders by replacing technique like endoscopy. Smart pills dispenser are automatic medication dispenser that helps in scheduling, organizing, and delivering patient medication with the touch of button. Smart pills dispenser uses Microchip AVR-IoT board with WiFi capabilities for communicating with AWS system. Smart pills box is web-based and mobile application that helps patients for taking their medications. Pill organizer benefits an individual who takes supplements and several medications. Rising chronic diseases and demand for minimally invasive surgeries has given positive impact on target market growth.

Rise in prevalence of chronic diseases and rate of urbanization

Rise in prevalence of chronic diseases and rate of urbanization is one of the leading factors for the Smart Pills Market growth. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, which are unhealthy and affected the gut microbiota in human being. Urbanization has given rise in disposable income which allows the individual to enhance their lifestyle, consuming high amount of red meat and animal derived food, fats & oils, sugar, sodium, which has affected the digestive health. Urbanization has caused change in diet. Eating processed and unhealthy food, lack of exercise affect the health causing chronic disease like heart disease, diabetes, obesity, high blood pressure, gastrointestinal diseases, etc. Consumption of unhealthy and processed food cause the indigestion, constipation, acidity, bloating of stomach, belching, flatulence, vomiting, feeling uncomfortable, feeling heavy, etc. which has led in rising gastrointestinal diseases.

In 2022, according to National Institute of Diabetes and Digestive and Kidney Diseases between 60 million to 70 million Americans are suffering from gastrointestinal disorders which has led to 250,000 deaths each year.  Smart Pills helps in diagnosing and treating gastrointestinal disease by providing painless, and easy procedure for collecting gastrointestinal data without using any radiation. Smart Pills helps in measuring movement and motility of gut. For instance, in august 2021, Smart Pills has become powerful clinical tool and potential in diagnosis and treatment of gastrointestinal diseases. Smart Pills technology has provided simple, painless procedure in collecting gastrointestinal tract data without using radiation. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in chronic disease, and population in urban areas boosts the demand for Smart Pills Market.

Rise in demand for minimally invasive surgery

Rise in demand for minimally invasive procedure has become the major factor in target market growth. Expansion of minimally invasive surgery has been increasing rapidly. Instead of open surgery minimally invasive surgery are simple and painless. Instead of opening body and cutting through larger areas of tissues to operate, minimally invasive surgery has allowed surgeon to just make a small surgical incisions for gaining access to body and organs which able to operate faster with less injury to patient. Smart pill capsule motility procedure is less invasive procedure and performed under 30 minutes. Rising demand for minimally invasive surgical procedures has provide innovative techniques like capsule endoscopy. Capsule endoscopy has played a vital role in early diagnosis and treatment of chronic diseases. Moreover, rising demand for minimally invasive surgeries which includes smart pills due to its painless and simple procedure has propelled the growth of the Smart Pills Market.

Restrains:

Some disadvantages like it has impact on patients privacy who are suffering from schizophrenia, may decrease physician and patient interaction which is important in face to face physical examination for fully diagnosing and treating patients, more sophisticated technology is required because smart pills requires specific monitoring. However, expensive cost and some disadvantages may somewhat restrain the Smart Pills Market growth.

Smart Pills Market is segmented based on target area, application, end-users and region.

Target Area Insight

On the basis of Target Area Smart Pills Market is segmented into Small Intestine, Large intestine, Stomach, and Esophagus.

Application Insights

On the basis of Application Smart Pills Market is segmented into Drug Delivery, Capsule Endoscopy and others. Capsule endoscopy has dominated the target market due to rising chronic disease like gastrointestinal diseases.

End-Users

On the basis of End-Users Smart Pills Market is segmented into Hospitals, Diagnostic Centers, Specialty Clinics and Research Institutes.

Regional Insights:

On region the Smart Pills Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising prevalence of chronic diseases, increase in colorectal cancer, technological advancement in healthcare development is anticipated to increase demand for Smart Pills in the region.

Smart Pills Market Report Scope:

Attribute	Details
Base year for estimation	2022
Forecast period	2022 – 2032
Market representation	Revenue in USD million & CAGR from 2022 to 2032
Market Segmentation	By Target Area - Small Intestine, Large Intestine, Stomach, and Esophagus By Application - Drug Delivery, Capsule Endoscopy and others By End-Users - Hospitals, Diagnostic Centers, Specialty Clinics and Research Institutes
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Smart Pills Market report based on ingredient, product, application, distribution channel and region:

Smart Pills Market, By Target Area:

• Small Intestine
• Large Intestine
• Stomach
• Esophagus

Smart Pills Market, By Application:

• Drug Delivery
• Capsule Endoscopy
• Others

Smart Pills Market, By End-Users:

• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Research Institutes

Smart Pills Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Smart Pills Market includes,

Medtronic

It is a global leader in medical technology, devices and therapies. It offers cardiac devices, smart pills, etc.

Olympus Corporation

It is the leading manufacturer of optical and digital precision technology and also provides innovative medical systems.

MEDISAFE

It is the world leader in Hi-Tech surgical reprocessing solutions. It provides safe, cost effective and reliable timely products and services.

HealthBeacon Plc.

It is the leading digital therapeutics company for injectable medications.

Otsuka Pharmaceutical Co. Ltd.

It offers products in oncology, neuroscience and digital innovation.

Boston Scientific Corporation

It offers products like coronary stents, pacemakers, implanted devices, cardiac resynchronization therapy devices and others.

CapsoVision Inc.

It is the innovator of global medical device specialized in field of capsule endoscopy, healthcare and other medical device.

Check Cap

It is the clinical stage medical diagnostic company which is developing first C-Scan capsule based system for colorectal cancer screening.

JINSHAN Science and Technology

It offers capsule endoscopy platform, reflux monitoring system, etc.

Novartis AG

It is the manufacturer of consumer healthcare products, pharmaceutical products with innovative science and technology.

Bio-Images Drug Delivery (BDD) Limited

It is the manufacturer and developer of biopharmaceutical products and oral drug formulations. It is specialized in versatile technology and gamma scintigraphy.

• In April 2023, the Da Vinci Xi robotic surgical system was launched by Apollo to provide advanced technology and advancements in surgical procedures. The Da Vinci Xi System facilitates minimally invasive surgeries, in which only small incisions are made. This results in less injury to the patient, less pain, and a faster recovery time compared to traditional open surgery. The system's advanced technology helps achieve better surgical results. Its high-resolution 3D vision system provides a clearer view of the surgical site, and instrument articulation allows for more precise tissue manipulation and suturing. In 2022, Semaglutide, an antidiabetic drug from Novo Nordisk, was launched in India, providing a new treatment alternative for people with type 2 diabetes of the glucagon-like peptide (GLP-1) receptor, Semaglutide showed excellent effects shows promise as a complement to diabetes management approaches.
• In September, 2022, HealthBeacon Plc., has launched new ‘HB Smart Pills’ management system which is an elegant device designed to be fit in patients home which will helps in managing nine oral medications. This newly launched smart pill solution will allow in notifying patient about requirement in prescription refilling and also able to record visual images of pill containers to medication adherence.

• HealthBeacon Plc. 
• Medtronic
• Olympus Corporation
• MEDISAFE
• Otsuka Pharmaceutical Co. Ltd.
• Boston Scientific Corporation
• CapsoVision Inc.
• Check Cap
• JINSHAN Science and Technology
• Novartis AG
• Bio-Images Drug Delivery (BDD) Limited